HIMS
xyz:
equity
· Hyperliquid
—
Equity perp — Hyperliquid synthetic derivative. For real-time exchange pricing, turn off the Crypto toggle and search the bare equity ticker.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Mark Price
$33.90
24h Change
-4.34%
Funding (8h)
+0.0082%
Open Interest
106,803
24h Volume
$2.32M
Oracle Price
$33.87
Mark − Oracle
+0.1717%
Prev Day Close
$35.44
As of (UTC)
2026-07-11 8:38:22
Daily candles — last 90 days
Funding rate history — last 7 days (8h cycles)
Positive funding = longs paying shorts (long-crowded). Negative = shorts paying longs (short-crowded).
Peers — same category
| Coin | Mark | 24h % |
|---|---|---|
| SKHX | $1474.70 | +0.16% |
| SKHY | $170.61 | +5.09% |
| MU | $985.87 | +1.96% |
| SNDK | $1927.10 | +7.49% |
| DRAM | $63.25 | +1.94% |
News headlines Yahoo Finance, 1h cache
-
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market
2026-07-07 21:45 · Yahoo
-
Hims & Hers (HIMS) Stock May Be Undervalued After FDA Peptide Questions
2026-07-07 03:19 · Yahoo
-
Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?
2026-07-07 01:05 · Yahoo
-
As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
2026-07-06 18:20 · Yahoo
-
HIMS Stock Rises Overnight: CEO Shrugs Off Wild Swings, Bets On ‘Gold Standard’ Of Healthcare Over Next Decade
2026-07-06 03:29 · Yahoo
-
Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?
2026-07-05 06:00 · Yahoo
-
HIMS Stock Hits 2026 High After Unlocking $400M Working Capital Through JPMorgan — Retail Gets Less Bearish
2026-07-02 01:41 · Yahoo
-
Sector Update: Healthcare Stocks Higher Late Afternoon
2026-07-01 19:48 · Yahoo
-
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
2026-07-01 13:00 · Yahoo
-
HIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’
2026-07-01 07:14 · Yahoo